Clinical Trial Update: Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with or without radiation therapy in adults with recurrent glioblastoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-17